Seeing Is Believing

Currently out of the existing stock ratings of Dae Gon Ha, 126 are a BUY (84.56%), 23 are a HOLD (15.44%).
Analyst Dae Gon Ha, carries an average stock price target met ratio of 37.97% that have a potential upside of 33.98% achieved within 121 days. Previously, Dae Gon Ha worked at STIFEL, BTIG, LEERINK.
Dae Gon Ha’s has documented 261 price targets and ratings displayed on 31 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 26-Feb-2026.
Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) at 6/17/2022. The price target of $25 was fulfilled within 59 days with a profit of $21.06 (534.52%) receiving and performance score of 90.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Feb-2022
$60
2 years 9 months 17 days ago
(18-Dec-2023)
0/2 (0%)
$60 (0.00%)
$2.04
$0.64 (45.71%)
$36
3 years 2 months 22 days ago
(13-Jul-2023)
0/2 (0%)
$2.04 (0.00%)
$2.04
$0.64 (45.71%)
$48
3 years 2 months 23 days ago
(12-Jul-2023)
0/5 (0%)
$2.04 (0.00%)
$6
$4.6 (328.57%)
$6
3 years 6 months 11 days ago
(24-Mar-2023)
0/5 (0%)
$6 (0.00%)
Hold Since 08-Dec-2022
$4
3 years 9 months 27 days ago
(08-Dec-2022)
0/3 (0%)
$4 (0.00%)